Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients

Lupus

Volumn 25, Issue 14, 2016, Pages 1577-1586

  Ma, R ^a   Jiang, W ^a   Li, Z ^a   Sun, Y ^a   Wei, Z ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

intrarenal T cells; Lupus nephritis; macrophage; osteopontin; podocytes; proteinuria

Indexed keywords

NEPHRIN; OSTEOPONTIN; MEMBRANE PROTEIN;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; GLOMERULUS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; KIDNEY BIOPSY; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; KIDNEY TUBULE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAJOR CLINICAL STUDY; MICROSCOPY; MOLECULAR PATHOLOGY; PODOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEINURIA; T LYMPHOCYTE; UPREGULATION; BIOPSY; CYTOLOGY; IMMUNOLOGY; MALE; METABOLISM; PATHOLOGY;

ADULT; BIOPSY; FEMALE; HUMANS; LUPUS NEPHRITIS; MACROPHAGES; MALE; MEMBRANE PROTEINS; OSTEOPONTIN; PODOCYTES; PROTEINURIA; T-LYMPHOCYTES;

EID: 84994078722     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316646861     Document Type: Article

References (29)

1. Mok CC,. Prognostic factors in lupus nephritis. Lupus 2005; 14: 39-44.
2. Mok CC,. Biomarkers for lupus nephritis: a critical appraisal. J Biomed Biotechnol 2010; 2010: 638413-638413.
3. Nowling TK, Gilkeson GS,. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther 2011; 13: 250-250.
4. Lewis EJ, Schwartz MM,. Pathology of lupus nephritis. Lupus 2005; 14: 31-38.
5. Reyes-Thomas J, Blanco I, Putterman C,. Urinary biomarkers in lupus nephritis. Clin Rev Allergy Immunol 2011; 40: 138-150.
6. Jefferson JA, Alpers CE, Shankland SJ,. Podocyte biology for the bedside. Am J Kidney Dis 2011; 58: 835-845.
7. Desai N, Cimbaluk D, Lewis EJ, Whittier WL,. Proteinuria in membranous lupus nephritis: the pathology is in the podocyte. Lupus 2013; 22: 461-468.
8. Migliorini A, Angelotti ML, Mulay SR, et al. The antiviral cytokines IFN-alpha and IFN-beta modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration. Am J Pathol 2013; 183: 431-440.
9. de Zubiria Salgado A, Herrera-Diaz C,. Lupus nephritis: an overview of recent findings. Autoimmune Dis 2012; 2012: 849684-849684.
10. Menke J, Bork T, Kutska B, et al. Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice. Kidney Int 2011; 79: 452-463.
11. Kariuki SN, Moore JG, Kirou KA, Crow MK, Utset TO, Niewold TB,. Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus. Genes Immun 2009; 10: 487-494.
12. Nystrom T, Duner P, Hultgardh-Nilsson A,. A constitutive endogenous osteopontin production is important for macrophage function and differentiation. Exp Cell Res 2007; 313: 1149-1160.
13. Schiffer L, Bethunaickan R, Ramanujam M, et al. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol 2008; 180: 1938-1947.
14. Hochberg MC,. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1725.
15. Wallace DJ, Hahn BH (eds). Dubois' Lupus Erythematosus. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2007.
16. Liao R, Liu Q, Zheng Z, et al. Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis. PloS One 2015; 10: e0132724-e0132724.
17. Kraft SW, Schwartz MM, Korbet SM, Lewis EJ,. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol 2005; 16: 175-179.
18. Liapis H, Romagnani P, Anders HJ,. New insights into the pathology of podocyte loss: mitotic catastrophe. Am J Pathol 2013; 183: 1364-1374.
19. Yap DY, Lai KN,. Pathogenesis of renal disease in systemic lupus erythematosus-the role of autoantibodies and lymphocytes subset abnormalities. Int J Mol Sci 2015; 16: 7917-7931.
20. Okamoto A, Fujio K, Tsuno NH, Takahashi K, Yamamoto K,. Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice. Kidney Int 2012; 82: 969-979.
21. Sun CY, Shen Y, Chen XW, et al. The Characteristics and Significance of Locally Infiltrating B Cells in Lupus Nephritis and Their Association with Local BAFF Expression. Int J Rheumatol 2013; 2013: 954292-954292.
22. Perysinaki GS, Moysiadis DK, Bertsias G, et al. Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology. Lupus 2011; 20: 781-791.
23. Kestila M, Lenkkeri U, Mannikko M, et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1: 575-582.
24. Tucci M, Stucci S, Strippoli S, Silvestris F,. Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus. J Biomed Biotechnol 2010; 2010: 457146-457146.
25. Kaleta B,. Role of osteopontin in systemic lupus erythematosus. Arch Immunol Ther Exp (Warsz) 2014; 62: 475-482.
26. Schordan S, Schordan E, Endlich K, Endlich N,. AlphaV-integrins mediate the mechanoprotective action of osteopontin in podocytes. Am J Physiol Renal Physiol 2011; 300 (1): F119-F132.
27. Lorenzen J1, Shah R, Biser A, Staicu SA, et al. The role of osteopontin in the development of albuminuria. J Am Soc Nephrol 2008; 19: 884-890.
28. Masutani K, Akahoshi M, Tsuruya K, et al. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum 2001; 44: 2097-2106.
29. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M,. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 1998; 152: 353-358.